Respiratory Syncytial Virus Vaccine Based on Chimeric Papillomavirus Virus-like Particles Or Capsomeres

The present invention is directed to a chimeric papillomavirus virus- like particle (VLP) or capsomere including an Ll polypeptide and, optionally, an L2 polypeptide, and a respiratory syncytial virus (RSV) protein or polypeptide fragment thereof comprising a first epitope, where the RSV protein or polypeptide fragment thereof is attached to one or both of the Ll and L2 polypeptides. Chimeric proteins, genetic constructions, and recombinant vectors and host cells suitable for expression of the constructs and making of the chimeric VLPs or capsomeres are also disclosed. Use of the VLPs or capsomeres, or a pharmaceutical composition containing the same, is contemplated for inducing a protective immune response against RSV.

Attached files:
WO 2009055491.jpg

Patents:
WO 2,009,055,491

Inventor(s): MURATA YOSHIHIKO [US]; ROSE ROBERT C [US]; WALSH EDWARD E [US]; FALSEY ANN R [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents

Share on      


CrowdSell Your Patent